Literature DB >> 8789446

A de novo case of hereditary neuropathy with liability to pressure palsies (HNPP) of maternal origin: a new mechanism for deletion in 17p11.2?

E LeGuern1, R Gouider, N Ravisé, J Lopes, S Tardieu, M Gugenheim, N Abbas, P Bouche, Y Agid, A Brice.   

Abstract

Hereditary neuropathy with liability to pressure palsies (HNPP) is an autosomal dominant neuropathy, most often associated with a deletion of the 17p11.2 region, which is duplicated in 70% of patients with Charcot-Marie-Tooth type 1 (CMT1A). Most de novo CMT1A and HNPP cases have been of paternal origin. A rare case of de novo HNPP of maternal origin was analysed to determine the underlying mechanism. Affected individuals in the family carried a deletion corresponding to the CMT1A/HNPP monomer unit associated with a rearrangement of the CMT1A-REP sequences. Segregation analysis of 17p11-p12 markers in the family indicated that the deletion was not generated by unequal crossing over between homologous 17 chromosomes, as in de novo cases from paternal origin, but rather by an intrachromosomal rearrangement. Two distinct mechanisms can therefore lead to the same 17p11.2 deletion. This result suggests that intrachromosomal rearrangement may be specific to maternal transmissions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8789446     DOI: 10.1093/hmg/5.1.103

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

1.  De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling.

Authors:  B Wirth; T Schmidt; E Hahnen; S Rudnik-Schöneborn; M Krawczak; B Müller-Myhsok; J Schönling; K Zerres
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

2.  Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: new tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A. French CMT Collaborative Research Group.

Authors:  J Lopes; E LeGuern; R Gouider; S Tardieu; N Abbas; N Birouk; M Gugenheim; P Bouche; Y Agid; A Brice
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

3.  The mechanisms involved in formation of deletions and duplications of 15q11-q13.

Authors:  W P Robinson; F Dutly; R D Nicholls; F Bernasconi; M Peñaherrera; R C Michaelis; D Abeliovich; A A Schinzel
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

4.  Detection of the CMT1A/HNPP recombination hotspot in unrelated patients of European descent.

Authors:  V Timmerman; B Rautenstrauss; L T Reiter; T Koeuth; A Löfgren; T Liehr; E Nelis; K D Bathke; P De Jonghe; H Grehl; J J Martin; J R Lupski; C Van Broeckhoven
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

5.  Escape from het-6 incompatibility in Neurospora crassa partial diploids involves preferential deletion within the ectopic segment.

Authors:  M L Smith; C J Yang; R L Metzenberg; N L Glass
Journal:  Genetics       Date:  1996-10       Impact factor: 4.562

6.  Identification of Alu elements mediating a partial PMP22 deletion.

Authors:  Verena Matejas; Kathrin Huehne; Christian Thiel; Claudia Sommer; Sibylle Jakubiczka; Bernd Rautenstrauss
Journal:  Neurogenetics       Date:  2006-03-29       Impact factor: 2.660

7.  Severe phenotypes in a Charcot-Marie-Tooth 1A patient with PMP22 triplication.

Authors:  Sung Min Kim; Jinho Lee; Bo Ram Yoon; Ye Jin Kim; Byung-Ok Choi; Ki Wha Chung
Journal:  J Hum Genet       Date:  2014-12-11       Impact factor: 3.172

Review 8.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

9.  Paternal gender specificity and mild phenotypes in Charcot-Marie-Tooth type 1A patients with de novo 17p12 rearrangements.

Authors:  Ah J Lee; Da E Nam; Yu J Choi; Seung W Noh; Soo H Nam; Hye J Lee; Seung J Kim; Gyun J Song; Byung-Ok Choi; Ki W Chung
Journal:  Mol Genet Genomic Med       Date:  2020-07-09       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.